Department of Pharmaceuticals | Government of India

भारत सरकारGovernment of india
रसायन और उर्वरक मंत्रालयMinistry of Chemicals and Fertilizers

Skip to main content
Search
The Web PHARMACEUTICALS.GOV.IN

Search
- A⁺
- A
- A^-
- A
- A
Language
- हिन्दी

Other Links

Ranbaxy says Toansa unit ban will hit US business by 10-12%

Ranbaxy says Toansa unit ban will hit US business by 10-12%

Attachment File: Download (38.28 KB)
Neuland labs profit doubles in Q3

Neuland labs profit doubles in Q3

Attachment File: Download (21.58 KB)
Relief for Ranbaxy laboratories but questions still remain

Relief for Ranbaxy laboratories, but questions still remain

Attachment File: Download (60.19 KB)
GSK posts $8.8 billion profit

GSK posts $8.8 billion profit

Attachment File: Download (68.87 KB)
Ranbaxy net loss narrows

Ranbaxy net loss narrows

Attachment File: Download (30 KB)
Sets aside Rs. 257.4cr for impact of USFDA ban

Sets aside Rs. 257.4cr for impact of USFDA ban

Attachment File: Download (77.88 KB)
Quarterly loss of Ranbaxy reduced

Quarterly loss of Ranbaxy reduced.

Attachment File: Download (33.02 KB)
Venus Remedies unit gets GMP certification

Venus Remedies unit gets GMP certification

Attachment File: Download (23.39 KB)
Mylan brings breast cancer drug to India

Mylan brings breast cancer drug to India

Attachment File: Download (25.25 KB)
Daiichi may step in to resolve Ranbaxy US FDA issues

Daiichi may step in to resolve Ranbaxy's US FDA issues

Attachment File: Download (59.23 KB)

Pages